Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 489261 - 489280 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EX09) nintedanib (adm: O) | OFEV 150MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Idiopathic Pulmonary Fibrosis | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EX13) gilteritinib (adm: O) | XOSPATA 40MG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute | AstellasPharmaU.S.,Inc. |
| USA | (L01EX14) entrectinib (adm: O) | ROZLYTREK 100MG CAPSULE | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cancer;Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX14) entrectinib (adm: O) | ROZLYTREK 100MG CAPSULE | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cancer;Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX14) entrectinib (adm: O) | ROZLYTREK 200MG CAPSULE | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cancer;Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX14) entrectinib (adm: O) | ROZLYTREK 200MG CAPSULE | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cancer;Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX14) entrectinib (adm: O) | ROZLYTREK 50MG PELLET PKT | 42 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cancer;Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX14) entrectinib (adm: O) | ROZLYTREK 50MG PELLET PKT | 42 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cancer;Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX21) tepotinib (adm: O) | TEPMETKO 225MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | EMDSerono,Inc. |
| USA | (L01EX21) tepotinib (adm: O) | TEPMETKO 225MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | EMDSerono,Inc. |
| USA | (L01EX21) tepotinib (adm: O) | TEPMETKO 225MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | EMDSerono,Inc. |
| USA | (L01EX21) tepotinib (adm: O) | TEPMETKO 225MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | EMDSerono,Inc. |
| USA | (L01EX23) pralsetinib (adm: O) | GAVRETO 100MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | RigelPharmaceuticals,Inc. |
| USA | (L01EX23) pralsetinib (adm: O) | GAVRETO 100MG CAP,ORAL | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | RigelPharmaceuticals,Inc. |
| USA | (L01EX23) pralsetinib (adm: O) | GAVRETO 100MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX23) pralsetinib (adm: O) | GAVRETO 100MG CAP,ORAL | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX23) pralsetinib (adm: O) | GAVRETO 100MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | RigelPharmaceuticals,Inc. |
| USA | (L01EX23) pralsetinib (adm: O) | GAVRETO 100MG CAP,ORAL | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | RigelPharmaceuticals,Inc. |
| USA | (L01EX23) pralsetinib (adm: O) | GAVRETO 100MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX23) pralsetinib (adm: O) | GAVRETO 100MG CAP,ORAL | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
